This story was originally published May 15.

In one of the first published examples of Life Technologies' Ion AmpliSeq-Cancer Panel in the clinic, researchers from the University of British Columbia used the panel to interrogate two tumor samples from an unusual pediatric brain cancer case.

The researchers demonstrated that the technology could deliver results within three days of sample collection using only 10 nanograms of DNA. While the findings were not immediately clinically actionable, the team did uncover a rare mutation to the MET gene.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.